XML 88 R73.htm IDEA: XBRL DOCUMENT v3.20.2
Business Combinations - Purchase Price Allocation Focal Therapeutics (Details) - USD ($)
$ in Millions
Sep. 26, 2020
Sep. 28, 2019
Oct. 01, 2018
Business Acquisition [Line Items]      
Goodwill $ 2,657.9 $ 2,563.7  
Focal Therapeutics      
Business Acquisition [Line Items]      
Cash     $ 2.2
Accounts receivable     2.0
Inventory     7.9
Other assets     0.5
Accounts payable and accrued expenses     (5.6)
Long-term debt     (2.5)
Deferred income taxes, net     (12.7)
Goodwill     31.1
Purchase Price     120.1
Focal Therapeutics | Developed technology      
Business Acquisition [Line Items]      
Identifiable intangible assets:     83.1
Focal Therapeutics | In-process research and development      
Business Acquisition [Line Items]      
Identifiable intangible assets:     11.4
Focal Therapeutics | Trade names      
Business Acquisition [Line Items]      
Identifiable intangible assets:     $ 2.7